全球主动脉瘤市场-全球产业分析,规模,份额,成长,趋势,预测(2031)-按类型、按治疗、按产品、按最终用户、按地区
市场调查报告书
商品编码
1420353

全球主动脉瘤市场-全球产业分析,规模,份额,成长,趋势,预测(2031)-按类型、按治疗、按产品、按最终用户、按地区

Aortic Aneurysm Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日期: | 出版商: Fairfield Market Research | 英文 296 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球主动脉瘤市场规模为39.1亿美元,预计在2024年至2031年的预测期内将呈现显着成长,预计将达到96.1亿美元。

动脉粥状硬化的盛行率日益增加及其相关风险是市场成长的主要驱动力。世界老年人口的增加大大增加了患者数量。美国卫生与公共服务部预测老年人口将大幅增加,预计到 2040 年将达到 808 亿,2060 年将达到 947 亿。吸烟是主动脉瘤发生的重要危险因素,全球烟草使用的盛行正在促进市场成长。对微创手术的需求不断增长和有利的医疗报销政策进一步推动了市场扩张。

大众对主动脉瘤及其治疗费用缺乏认识阻碍了市场的成长。与主动脉瘤治疗相关的併发症,如髂骨穿孔、支架狭窄、内漏和远端张力,是市场上的挑战。在已开发国家,迟迟没有用EVAR等微创手术取代传统手术已成为值得注意的市场问题。

本报告研究了全球主动脉瘤市场,并提供了市场概述,包括按类型、治疗、产品、最终用户、区域划分的趋势以及进入市场的公司的竞争趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第三章全球主动脉瘤市场展望,2018-2031

  • 2018-2031 年全球主动脉瘤市场前景,按类型和价值(十亿美元)
  • 全球主动脉瘤市场前景(按治疗方法)、价值(十亿美元),2018-2031 年
  • 全球主动脉瘤市场展望,按产品,价值(十亿美元),2018-2031
  • 全球主动脉瘤市场展望,按最终用户划分,价值(十亿美元),2018-2031 年
  • 全球主动脉瘤市场展望,按地区,价值(十亿美元),2018-2031

第 4 章 2018-2031 年北美主动脉瘤市场展望

第五章欧洲主动脉瘤市场展望,2018-2031

第六章 2018-2031 年亚太地区主动脉瘤市场展望

第 7 章 2018-2031 年拉丁美洲主动脉瘤市场展望

第 8 章 2018-2031 年中东和非洲主动脉瘤市场展望

第9章 竞争格局

  • 按产品和处理划分的热图
  • 按製造商和处理方式划分的热图
  • 2023 年公司市场份额分析
  • 比赛仪表板
  • 公司简介
    • Medtronic
    • Endologix LLC
    • Gore Medical
    • MicroPort Scientific Corporation
    • Cook
    • JOTEC
    • Cardinal Health
    • Terumo Corporation
    • Lombard Medical
    • AbbVie Inc.

第10章附录

简介目录

The global aortic aneurysm market, valued at US$ 3.91 Billion in 2024, is set to exhibit remarkable growth during the forecast period from 2024 to 2031. This substantial growth trajectory aims to accumulate a market value of US$ 9.61 Billion by 2031.

Factors Driving Market Growth:

The growth of the aortic aneurysm market can be attributed to several pivotal factors:

  • Increasing Prevalence of Atherosclerosis: The rising incidence of atherosclerosis and its associated risks have become major drivers of market growth.
  • Rising Geriatric Population: The expanding elderly population globally is contributing significantly to the patient pool. The U.S. Department of Health and Human Services predicts a substantial increase in the elderly population, reaching 80.8 Billion by 2040 and 94.7 Billion by 2060.
  • Smoking-Related Risk: Smoking is a significant risk factor for developing aortic aneurysms, and the global prevalence of tobacco use is contributing to the market growth.
  • Minimally Invasive Procedures: The increasing demand for minimally invasive procedures and favorable health reimbursement policies are further augmenting market expansion.

Challenges Faced by the Aortic Aneurysm Market:

Despite the positive growth prospects, the market faces certain challenges, including-

  • Lack of Awareness: Limited awareness among the general public about aortic aneurysms and the cost associated with their treatment is hampering market growth.
  • Complications: Complications related to aortic aneurysm treatment, such as iliac perforation, stent stenosis, endoleaks, and end tension, pose challenges to the market.
  • Traditional vs. Minimally Invasive Procedures: The slow replacement of traditional surgical procedures by minimally invasive surgeries, such as EVAR, in advanced countries is a noteworthy market challenge.

Regional Insights:

  • North America: Rapid technological advancements, a shift toward minimally invasive procedures, and the implementation of health screening programs have positioned North America as a prominent market, accounting for 47% of the aortic aneurysm market share in 2022.
  • Europe: Europe's significant market share can be attributed to technological advancements and the high prevalence of atherosclerosis. National organizations, such as the National Health Service (NHS), are actively working to reduce aortic aneurysm incidences.
  • Asia Pacific: The Asia Pacific region is expected to witness substantial growth due to a rising aging population, an increased prevalence of cardiovascular diseases, and growing disposable income. The presence of a sizable aging population is favoring market expansion.

Competitive Analysis:

Key players in the aortic aneurysm market are actively involved in research, product development, and collaborations to enhance their market presence. Some notable developments include:

  • In March 2021, Cook Medical, Inc. received FDA breakthrough device designation for Zenith Fenestrated+ Endovascular Graft (ZFEN+), used in treating intravascular AA.
  • Endologix LLC is expanding its geographical presence by selling EVAR products in multiple countries, including the U.S., Canada, New Zealand, South Korea, and Europe.

Key Companies Profiled:

  • Medtronic
  • Endologix LLC
  • Gore Medical
  • MicroPort Scientific Corporation
  • Cook
  • JOTEC
  • Cardinal Health
  • Terumo Corporation
  • Lombard Medical
  • AbbVie Inc.

Key Segments Profiled in the Aortic Aneurysm Industry Survey

Aortic Aneurysm by Type

  • Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
  • Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)

Aortic Aneurysm Treatment

  • Aortic Aneurysm by Open Surgical Repair (OSR)
  • Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)

Aortic Aneurysm Product

  • Aortic Aneurysm by Stent Grafts
  • Aortic Aneurysm by Catheters

Aortic Aneurysm End User

  • Aortic Aneurysm by Hospitals
  • Aortic Aneurysm by Ambulatory Surgery Centers
  • Aortic Aneurysm by Clinics

Aortic Aneurysm Region

  • North America Aortic Aneurysm Market
  • Latin America Aortic Aneurysm Market
  • Europe Aortic Aneurysm Market
  • Asia Pacific Aortic Aneurysm Market
  • Middle East & Africa Aortic Aneurysm Market

Table of Contents

1. Executive Summary

  • 1.1. Global Aortic Aneurysm Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aortic Aneurysm Market Outlook, 2018 - 2031

  • 3.1. Global Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 3.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 3.2. Global Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 3.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 3.3. Global Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Aortic Aneurysm by Stent Grafts
      • 3.3.1.2. Aortic Aneurysm by Catheters
  • 3.4. Global Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Aortic Aneurysm by Hospitals
      • 3.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 3.4.1.3. Aortic Aneurysm by Clinics
  • 3.5. Global Aortic Aneurysm Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Aortic Aneurysm Market Outlook, 2018 - 2031

  • 4.1. North America Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 4.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 4.2. North America Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 4.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 4.3. North America Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Aortic Aneurysm by Stent Grafts
      • 4.3.1.2. Aortic Aneurysm by Catheters
  • 4.4. North America Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Aortic Aneurysm by Hospitals
      • 4.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 4.4.1.3. Aortic Aneurysm by Clinics
  • 4.5. North America Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aortic Aneurysm Market Outlook, 2018 - 2031

  • 5.1. Europe Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 5.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 5.2. Europe Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 5.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 5.3. Europe Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Aortic Aneurysm by Stent Grafts
      • 5.3.1.2. Aortic Aneurysm by Catheters
  • 5.4. Europe Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Aortic Aneurysm by Hospitals
      • 5.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 5.4.1.3. Aortic Aneurysm by Clinics
  • 5.5. Europe Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aortic Aneurysm Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 6.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 6.2. Asia Pacific Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 6.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 6.3. Asia Pacific Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Aortic Aneurysm by Stent Grafts
      • 6.3.1.2. Aortic Aneurysm by Catheters
  • 6.4. Asia Pacific Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Aortic Aneurysm by Hospitals
      • 6.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 6.4.1.3. Aortic Aneurysm by Clinics
  • 6.5. Asia Pacific Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aortic Aneurysm Market Outlook, 2018 - 2031

  • 7.1. Latin America Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 7.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 7.2. Latin America Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Aortic Aneurysm by Open Surgical Repair (OSR)
      • 7.2.1.2. Aortic Aneurysm by Endovascular Aneurysm Repair (EVAR)
  • 7.3. Latin America Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Aortic Aneurysm by Stent Grafts
      • 7.3.1.2. Aortic Aneurysm by Catheters
  • 7.4. Latin America Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Aortic Aneurysm by Hospitals
      • 7.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 7.4.1.3. Aortic Aneurysm by Clinics
  • 7.5. Latin America Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aortic Aneurysm Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aortic Aneurysm Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Aortic Aneurysm by Thoracic Aortic Aneurysm (TAA)
      • 8.1.1.2. Aortic Aneurysm by Abdominal Aortic Aneurysm (AAA)
  • 8.2. Middle East & Africa Aortic Aneurysm Market Outlook, by Treatment, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Peripheral Arterial Disease
      • 8.2.1.2. Peripheral Aneurysms
      • 8.2.1.3. In Stent Restenosis
      • 8.2.1.4. Others
  • 8.3. Middle East & Africa Aortic Aneurysm Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Aortic Aneurysm by Stent Grafts
      • 8.3.1.2. Aortic Aneurysm by Catheters
  • 8.4. Middle East & Africa Aortic Aneurysm Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Aortic Aneurysm by Hospitals
      • 8.4.1.2. Aortic Aneurysm by Ambulatory Surgery Centers
      • 8.4.1.3. Aortic Aneurysm by Clinics
  • 8.5. Middle East & Africa Aortic Aneurysm Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Aortic Aneurysm Market by Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Aortic Aneurysm Market Treatment, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Aortic Aneurysm Market Product, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Aortic Aneurysm Market End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs Treatment Heatmap
  • 9.2. Manufacturer vs Treatment Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Medtronic
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Endologix LLC
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Gore Medical
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. MicroPort Scientific Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Cook
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. JOTEC
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Cardinal Health
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Terumo Corporation
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Lombard Medical
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. AbbVie Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations